hth官方网页版中国有限公司hth官方网页版中国有限公司

0571-87968248 CHINESE
  • Home
  • About us
    ProfileCultureHistory
  • News
    Company newsTrade showsIndustry news
  • Products
    COVID-19 IgG/IgM Rapid Test KitAllergen-specific IgE antibodies test kit seriesFood-specific IgG/IgG4 antibodies test seriesSingle/Polynomial allergen test seriesSingle allergen component test seriesGenetic test for allergic diseases series productsOther seriesProduct specific equipment
  • About allergies
    Scientific literaturePopular scienceVideos
  • Contact us
    Join usContact us
Scientific literaturePopular scienceVideos
Components literatureGene literatureMechanism literatureProbioticsTest literatureDesensitizationOther

Release date:2019-04-15


Allergy                                                     
[IF:6.048]
Intranasal administration of probiotic Lactobacillus rhamnosus GG prevents birch pollen-induced allergic asthma in a murine model 
DOI: 10.1111/all.13502
Abstract:
Background: There is an increasing interest in targeted application of probiotic bacteria for prevention and treatment of airway diseases, including allergies. Here, we investigated the beneficial effects of preventive intranasal treatment with probiotics Lactobacillus rhamnosus GG and L. rhamnosus GR-1 in a mouse model of allergic asthma.
Methods: L. rhamnosus was administered intranasally eight times on days 1-4 and 8-11 at 5x108 CFU/dose, followed by a two-week asthma induction protocol with birch pollen extract on alternating days. Effects of preventive treatment were analyzed based on serum antibody levels, bronchoalveolar lavage cell counts, lung histology, lung cytokine levels and airway hyperreactivity. Colonization and translocation of L. rhamnosus was assessed by bacterial cell counts in nasal mucosa, fecal samples, cervical lymph nodes and blood. Binding of fluorescent L. rhamnosus to fixed murine nasal mucosal cells and airway macrophages was visualized by fluorescence microscopy.
Results: Transient colonization of the murine upper airways by L. rhamnosus GG was demonstrated and was approximately ten times higher compared to L. rhamnosus GR-1.Marked binding of fluorescent L. rhamnosus GG to murine nasal mucosal cells and airway macrophages was visualized. Preventive treatment with L. rhamnosus GG (but not L.rhamnosus GR-1) resulted in a significant decrease in bronchoalveolar lavage eosinophil counts, lung interleukin-13 and interleukin-5 levels, and airway hyperreactivity. A tendency towards a decrease in serum Bet v 1-specific IgG1was likewise observed.
Conclusion: Intranasally administered L. rhamnosus GG prevents the development of cardinal features of birch pollen-induced allergic asthma in a strain-specific manner.
First Author:
Irina Spacova
Correspondence:
University of Antwerp, Department of Bioscience Engineering,Groenenborgerlaan 171, G.V.521, B-2020 Antwerp, Belgium
All Authors:
Irina Spacova, Mariya I. Petrova, Astrid Fremau, Lore Pollaris, JeroenVanoirbeek, Jan L. Ceuppens, Sven Seys, Sarah Lebeer
2019-02-15  Article
  • Home
  • About us
  • News
  • Products
  • About allergies
  • Contact us
Hangzhou Zheda Dixun Biological Gene Engineering Co., Ltd.  Copyright    HZKC Technical support   浙ICP备14005341号   (浙)-非经营性-2019-0050
Address: Rm.201-209, Bldg.2, No.568 Binkang Rd., Binjiang Dist.      Tel: 0571-87968248-805     Website:www.szzyfzls.com

COPYRIGHT©2003-2024 www.szzyfzls.com CORPORATION. ALL RIGHTS RESERVED

Official WeChat

乐动网页版 | 江南游戏 | 开云在线登录 | 江南游戏 | 开云电子(中国)有限公司官网 | 乐竞网页版登录入口 | 九州平台 | 冠盈体育(中国)科技有限公司官网 | 乐动手机网页版登录入口 |